FDA Consulting
FDA consulting from former FDA investigators and compliance officers with direct experience inspecting and regulating medical device, pharmaceutical, and combination product manufacturers. Our team provides regulatory insight, FDA inspection readiness guidance, and practical solutions based on real regulatory experience.
Pharmaceutical & Combination
FDA Consulting for pharmaceutical and combination product manufacturers, including CGMP compliance and 21 CFR Part 4 requirements, inspection readiness, and mock FDA inspections.
Medical Device & IVD
FDA Consulting for medical device and IVD manufacturers covering quality systems, inspection readiness, mock FDA inspections, and regulatory compliance support.
Global GxP Compliance
Global GxP compliance consulting supporting manufacturers with regulatory readiness, quality systems, and inspection preparation across international regulatory environments.
Why FDA Consulting Is Difficult to Find
- Finding the right FDA consulting expert is far more difficult than most companies realize. Former FDA investigators with direct knowledge of specific products, manufacturing operations, and regulatory expectations are rare.
- Modern FDA investigators are highly specialized. Many investigators gain experience in only one regulatory area or limited manufacturing operations. As a result, companies often discover that a former FDA investigator may not fully understand their specific products, processes, or quality systems.
- Even highly ranked former FDA officials may have extensive policy and regulatory knowledge, but practical experience with manufacturing operations such as process validation, sterilization validation, or laboratory controls can vary significantly.
- Companies frequently must evaluate whether an individual consultant truly understands their technology, manufacturing environment, and regulatory obligations.
Former FDA Investigators and Compliance Officers
Our FDA consulting team includes former FDA investigators and compliance officers with direct experience inspecting and regulating medical device, pharmaceutical, IVD, and combination product manufacturers. These professionals have evaluated manufacturing operations, quality systems, and regulatory compliance during FDA inspections. Their experience provides practical insight into how FDA investigators review documentation, assess quality system implementation, and identify potential regulatory concerns. By applying this real-world regulatory experience, our consultants help organizations strengthen compliance programs, improve inspection readiness, and better understand regulatory expectations.
Our consultants have first-hand experience with:
Medical Device Manufacturing Inspections
FDA inspections of medical device manufacturers evaluate whether quality systems and manufacturing operations comply with regulatory requirements. Investigators review design controls, production processes, CAPA systems, supplier management, complaint handling, and documentation practices. These inspections verify that procedures are properly implemented, records are maintained, and manufacturing activities consistently support product safety, effectiveness, and regulatory compliance.
Pharmaceutical CGMP Inspections
FDA inspections of pharmaceutical manufacturers focus on compliance with current Good Manufacturing Practice requirements under 21 CFR Parts 210 and 211. Investigators review production controls, laboratory operations, validation programs, data integrity practices, and quality oversight systems. These inspections ensure that drug manufacturing processes consistently produce products meeting established quality, safety, identity, strength, and purity requirements.
Combination Product Regulatory Oversight
Combination products involve both drug and device components and are regulated under multiple regulatory frameworks. FDA inspections evaluate compliance with 21 CFR Part 4 requirements along with applicable drug and device CGMP regulations. Investigators review manufacturing operations, quality system integration, documentation practices, and validation programs to ensure regulatory requirements for both product components are met.
Warning Letter Evaluation and Resolution
FDA warning letters are issued when investigators identify significant regulatory violations during inspections or compliance evaluations. Understanding the underlying issues and regulatory expectations is critical for an effective response. Our consultants review warning letter observations, evaluate root causes, and help organizations develop corrective actions that address regulatory concerns and strengthen long-term compliance with applicable FDA requirements.
Media Fill Validation for Sterile Drug Manufacturing
Media fill studies verify the effectiveness of aseptic manufacturing processes used in sterile pharmaceutical production. During FDA inspections, investigators evaluate media fill protocols, execution, documentation, and contamination control practices. These simulations demonstrate whether aseptic processes consistently prevent microbial contamination and ensure sterile product integrity under routine manufacturing conditions and during worst-case operational scenarios.
Process Validation
Process validation and cleanroom validation demonstrate that manufacturing processes and controlled environments consistently operate within defined parameters. FDA investigators review validation protocols, qualification reports, environmental monitoring, and ongoing verification activities. These evaluations confirm that manufacturing processes, equipment, and cleanroom environments maintain consistent product quality, contamination control, and compliance with applicable regulatory requirements.
Because our experts have conducted regulatory inspections and compliance evaluations, they understand how FDA investigators review documentation, assess quality systems, and identify potential regulatory risks. This experience allows our consultants to provide practical guidance that helps manufacturers strengthen compliance programs and improve inspection readiness.
Why Manufacturers Use FDA Consulting Retainers
Maintaining in-house FDA expertise can be difficult and costly. Former FDA investigators with direct experience inspecting specific products, manufacturing operations, and regulatory frameworks are rare. While many organizations benefit from this level of regulatory insight, few require a full-time former FDA expert. In many cases, hiring such expertise can cost between $350,000 and $500,000 annually, making it impractical for routine regulatory needs.
Quality and regulatory teams frequently need reliable FDA insight when complex compliance questions arise, during inspection preparation, or when evaluating potential regulatory risks. However, these needs typically occur periodically rather than on a full-time basis.
Like an Extension of Your Team
An FDA consulting retainer allows manufacturers to access experienced regulatory professionals whenever guidance is needed. Our consultants function like an extension of your internal quality and regulatory teams, providing direct access to former FDA investigators and compliance officers with relevant inspection experience.
This model delivers trusted regulatory expertise without the cost and complexity of hiring a full-time employee. Organizations receive practical support for inspection readiness, regulatory questions, and compliance strategy without long-term personnel commitments, employee benefits, or additional administrative costs.
Access to Experienced Former FDA Experts
Former FDA investigators and compliance officers with relevant manufacturing experience are rare. Many companies struggle to find experts who truly understand their specific products, processes, and regulatory environment. Our consulting retainer provides direct access to experienced professionals who have conducted inspections and understand how the FDA evaluates compliance, documentation, and manufacturing operations.
Support for Quality and Regulatory Teams
Quality and regulatory teams often face complex compliance questions that require practical regulatory insight. Having access to experienced FDA professionals helps internal teams interpret regulatory expectations, evaluate potential risks, and make informed decisions. Our consulting retainer supports your staff with reliable guidance when regulatory questions arise during routine operations or inspection preparation.
Continuous FDA Inspection Readiness
Maintaining continuous FDA inspection readiness requires ongoing attention to procedures, documentation, and operational practices. Our consultants work with organizations to review quality systems, identify potential compliance gaps, and strengthen internal processes. Regular regulatory guidance helps ensure that personnel, records, and manufacturing operations remain prepared for FDA inspection at any time.
Cost-Effective Alternative to Full-Time FDA Experts
Hiring a full-time former FDA expert can be expensive and difficult to justify for many organizations. Most companies only require specialized regulatory expertise periodically. A consulting retainer provides access to experienced FDA professionals when needed, allowing organizations to obtain regulatory insight and inspection readiness support without maintaining a full-time internal position.
On-Demand FDA Consulting Support
Regulatory questions can arise at any time during product development, manufacturing operations, or inspection preparation. Our consulting retainer provides on-demand access to experienced FDA professionals who understand regulatory expectations. Organizations can obtain guidance through remote meetings, phone discussions, or document reviews whenever regulatory insight is needed.
Highly Confidential
Regulatory discussions often involve sensitive manufacturing information, quality system documentation, and internal compliance evaluations. Our FDA consulting services are conducted with strict professional confidentiality. All communications, document reviews, and regulatory discussions are handled securely to protect proprietary information, internal processes, and regulatory strategies while providing trusted guidance to your organization’s leadership and regulatory teams.
Your On-Demand FDA Subject Matter Experts
Our FDA consulting services provide an on-demand regulatory resource for your organization. When regulatory questions arise, your team can immediately consult experienced professionals who understand FDA inspection expectations, regulatory compliance, and how investigators evaluate quality systems and manufacturing operations.
Our consultants are available through:
-
-
Remote Regulatory Consulting
-
Email and Regulatory Questions
-
Phone and Teams Meetings
-
Mock FDA Inspection Support
-
This approach provides experienced regulatory guidance without the cost of maintaining full-time internal FDA specialists.
FDA Consulting Services
Our FDA consulting services help manufacturers strengthen regulatory compliance, prepare for FDA inspections, and address complex regulatory questions. Former FDA investigators and compliance officers review quality systems, manufacturing operations, and regulatory documentation to identify potential compliance gaps. Our consultants provide practical guidance based on real inspection experience, helping organizations improve inspection readiness, strengthen internal processes, and maintain ongoing regulatory compliance across medical device, pharmaceutical, IVD, and combination product manufacturing operations.
Mock FDA Inspection
A mock FDA inspection simulates the structure and approach used during an actual regulatory inspection. Former FDA investigators review quality systems, manufacturing operations, documentation practices, and personnel responses. This process helps identify potential compliance gaps, strengthen inspection readiness, and prepare employees to respond confidently to investigator questions before an official FDA inspection occurs at your facility.
FDA Inspection Readiness
FDA inspection readiness ensures that quality systems, manufacturing processes, and documentation are prepared for regulatory inspection. Our consultants review procedures, records, and operational practices to identify potential compliance gaps. This preparation helps organizations strengthen internal processes, ensure personnel understand inspection expectations, and maintain a consistent state of regulatory readiness for FDA inspections.
21 CFR 4, 210, 211, 212, 820 Compliance Support
Our consultants provide regulatory guidance for manufacturers operating under 21 CFR Parts 4, 210, 211, 212, and 820. We review quality systems, manufacturing controls, validation programs, and documentation practices to evaluate compliance with applicable regulations. This support helps organizations strengthen regulatory programs, address compliance risks, and prepare for FDA inspections across multiple regulated product categories.
Industries We Support
FDA regulatory requirements vary across medical device, pharmaceutical, IVD, BIMO, OTC, cosmetic, regulatory submissions, and combination product manufacturers. Each sector operates under different regulatory frameworks, manufacturing controls, and inspection expectations. Our FDA consulting services support organizations across these regulated industries by providing practical guidance on compliance, inspection readiness, and quality system improvement based on real FDA inspection experience.
Medical Device & In Vitro Diagnostic Manufacturers
We support medical device manufacturers with FDA consulting, inspection readiness, mock inspections, and quality system compliance under applicable device regulations.
Pharmaceutical Manufacturers
Our consultants assist pharmaceutical manufacturers with CGMP compliance, inspection readiness, and regulatory guidance under 21 CFR Parts 210 and 211.
Combination Product Manufacturers
We provide regulatory consulting for combination product manufacturers, including compliance support under 21 CFR Part 4 and alignment between drug and device regulatory requirements.
Foreign Manufacturers
Foreign manufacturers exporting products to the United States must comply with FDA regulatory requirements and inspection expectations for products entering the U.S. market. Our FDA consulting services help international manufacturers understand regulatory obligations, strengthen quality systems, and prepare for FDA inspection readiness to support compliance when supplying products to the United States.
Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps – Section 361)
Manufacturers of human cells, tissues, and cellular and tissue-based products regulated under Section 361 must comply with FDA requirements. We assist with compliance, quality system oversight, and preparation for FDA inspections of tissue establishments and HCT/Ps.
OTC and Dietary Supplement
CIRG provides regulatory support for OTC drug and dietary supplement companies entering the U.S. market. We assist with classification, labelling, claims, registration, FDA notifications, import requirements, GMP readiness, and post-market compliance. Our practical experience helps identify risks early, strengthen documentation, and prepare firms for Agency inspections and sustainable market entry.
Global Regulatory Affairs and GxP Compliance Support
Manufacturers operating internationally must comply with multiple regulatory frameworks and maintain consistent quality systems across global operations. Our consulting services support organizations with regulatory strategy, GxP compliance, and inspection readiness for products distributed in global markets. We help manufacturers strengthen regulatory programs, align quality systems with applicable requirements, and prepare for inspections conducted by regulatory authorities worldwide.
Frequently Asked Questions About FDA Consulting
What is an FDA consulting retainer program?
An FDA consulting retainer provides manufacturers with ongoing access to experienced regulatory professionals who support inspection readiness, compliance strategy, and regulatory decision making. Instead of hiring full-time regulatory staff, companies obtain continuous guidance from experts familiar with FDA inspection expectations and regulatory requirements.
Who typically uses an FDA consulting retainer?
FDA consulting retainers are commonly used by medical device, pharmaceutical, combination product, and IVD manufacturers that require ongoing regulatory guidance. Organizations often use this model when they need experienced FDA insight but do not require a full-time internal regulatory expert.
How does the FDA consulting retainer support inspection readiness?
The retainer program focuses on maintaining continuous FDA inspection readiness by reviewing quality systems, regulatory documentation, and manufacturing practices. Consultants help organizations identify potential compliance gaps and strengthen internal processes before an FDA inspection occurs.
What types of regulatory support are included?
Support may include inspection readiness strategy, quality system evaluations, compliance discussions, review of selected documentation, and guidance related to FDA observations or regulatory concerns. The objective is to strengthen compliance and reduce regulatory risk.
How do consultants work with internal quality and regulatory teams?
Consultants work closely with leadership, quality, and regulatory teams to provide regulatory insight when questions arise. Many organizations use retained consultants as an extension of their internal regulatory resources when evaluating compliance issues or preparing for inspections.
Can the program support companies preparing for their first FDA inspection?
Yes. Many companies preparing for their first FDA inspection use consulting retainers to strengthen quality systems, review procedures, and prepare personnel for regulatory interactions with FDA investigators.
Is the FDA consulting program only for U.S. manufacturers?
No. The program supports both U.S. and international manufacturers that distribute products in the United States and must comply with FDA regulatory requirements and inspection expectations.
How is the consulting scope determined for each manufacturer?
The scope of consulting support typically depends on factors such as product type, manufacturing complexity, regulatory risk level, and the condition of the organization’s quality system. Each program is tailored to the needs of the manufacturer.
Can the consulting team assist with mock FDA inspections?
Yes. Mock FDA inspections may be conducted as part of inspection readiness activities. These exercises simulate FDA inspection approaches and help identify potential compliance gaps before a regulatory inspection occurs.
Is the consulting relationship confidential?
Yes. All regulatory discussions, document reviews, and operational information shared during consulting activities are treated as confidential. Consulting services are advisory in nature and do not transfer regulatory responsibility from the manufacturer.
Why do companies hire FDA consultants instead of full-time staff?
Hiring a full-time former FDA expert can be expensive and difficult, especially when specialized regulatory knowledge is only needed periodically. FDA consultants provide experienced regulatory insight when needed, helping organizations address compliance questions, prepare for inspections, and strengthen quality systems without maintaining full-time regulatory personnel.
What experience should an FDA consulting expert have?
Effective FDA consultants typically have direct regulatory inspection or compliance experience with manufacturing operations similar to the client’s products. Practical experience with quality systems, manufacturing controls, and regulatory inspections allows consultants to provide guidance aligned with FDA expectations.
Can FDA consultants help prevent regulatory observations?
Experienced FDA consultants help organizations identify compliance gaps before they are discovered during regulatory inspections. By reviewing quality systems, documentation practices, and operational controls, consultants help manufacturers strengthen regulatory compliance and reduce the likelihood of FDA inspection observations.
What types of manufacturers benefit most from FDA consulting?
Manufacturers operating in regulated industries such as medical devices, pharmaceuticals, in vitro diagnostics, and combination products often benefit from FDA consulting. Companies preparing for inspections, expanding manufacturing operations, or addressing complex compliance questions frequently use regulatory consultants.
How do FDA consultants support regulatory strategy?
FDA consultants provide insight into regulatory expectations, inspection practices, and compliance risks. This guidance helps organizations make informed decisions regarding quality systems, manufacturing controls, documentation practices, and regulatory responses when compliance concerns arise.
What does an FDA consultant do?
An FDA consultant provides regulatory guidance to manufacturers on compliance with FDA regulations. Consultants help organizations interpret regulatory requirements, prepare for inspections, evaluate quality systems, and address potential compliance issues before they become regulatory observations or enforcement actions.
When should a company hire an FDA consultant?
Companies often hire FDA consultants when preparing for regulatory inspections, addressing compliance concerns, developing quality systems, or responding to regulatory observations. Consulting support may also be used when internal teams require additional regulatory expertise for complex manufacturing or compliance questions.
What industries require FDA consulting?
FDA consulting services commonly support medical device manufacturers, pharmaceutical companies, in vitro diagnostic manufacturers, and combination product manufacturers. Organizations involved in regulated manufacturing often require regulatory guidance to maintain compliance and prepare for FDA inspections.
How does a mock FDA inspection work?
A mock FDA inspection simulates the structure and approach used during an FDA regulatory inspection. Former FDA investigators review documentation, manufacturing operations, and quality systems to identify potential compliance gaps and help organizations strengthen inspection readiness before an actual FDA inspection occurs.
How long does FDA inspection preparation take?
The time required for FDA inspection preparation depends on the size of the organization, the complexity of manufacturing operations, and the condition of the quality system. Some organizations require targeted reviews, while others benefit from broader assessments to strengthen inspection readiness.